CTRI/2019/08/020742尚未招募未知
An open label clinical study to evaluate efficacy and safety of hair serum in healthy adult male and female volunteers with hairfall.
Sami Labs Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Male and female subjectsâ?? in general good health.
- •2 Subjects in the age group 25 to 45 years (both the ages inclusive).
- •3 Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4 Hair density of greater than 100 and less than 200 hair follicle per square cm as per Trichoscan measurement
- •5 Female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per photo numerical10-point scale (Linear scale for assessment purpose-MSCR Scale).
- •6 Male subjects falling under Grade 3â?? Grade 6 of hair loss severity grade evaluated as per photo numerical10-point scale (Linear scale for assessment purpose - MSCR Scale).
- •7 Subjects willing to abide by and comply with the study protocol.
- •8 Subjects who have not participated in a similar investigation in the past three months.
- •9 Subjects complaining of hair fall and damage.
- •10 Healthy volunteers with no known allergy as established by medical history.
- •11 Subjects who do not smoke or drink
- •12 Subjects who are not crash dieting.
- •13 Subjects who agree to refrain from using hair dye/hair colour during the study period.
- •14 Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration.
- •15 Subjects who are willing to refrain from any other oil treatment/hair spa and oral medications for hair growth during the study.
排除标准
- •1 Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •2 Subjects having any active scalp diseasesuch as scalp Psoriasiswhichmayinterfere in the study- dermatologistâ??s judgement.
- •3 Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •4 Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania.
- •5 Subjects who have had hair transplant.
- •6 Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia.
- •7 Subjects with a known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •8 Subjects consuming alcohol and smoking
- •9 Subjects on oral medications such as vitamin supplements, including multi-vitaminswhich will compromise the study.
- •10 Subjects who are pregnant or lactating or nursing as established with medical history
- •11 Subjects under medical treatment for hair problems, prescription drugs such as Minoxidil, Finasteride, or any 5 α-reductase inhibitor or light therapy.
- •12 Subjects undergoing any chemical hair salon treatment-straightening/perming/colour.
- •13 Menopausal female subjects as determined by medical history.
- •14 Subjects with chronic illness which may influence the cutaneous state.
- •15 Subjects participating in other similar cosmetic or therapeutic trial within last three months.
- •16 Subjects with medical history of thyroid disorders.
- •17 Subjects with any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
- •18 Subjects who have experienced a known stressful event within the last 6 months such as death in family, miscarriage etc.
研究者
相似试验
已完成
4 期
A clinical study to evaluate efficacy and safety of Metronidazole Injection manufactured by Nirma Limited for the treatment of Lower Respiratory Tract Infections, Intra abdominal infections and other bacterial infections.CTRI/2012/09/002988irma Limited30
已完成
4 期
A clinical study to evaluate efficacy and safety of Ciprofloxacin Injection manufactured by Nirma Limited for the treatment of Lower Respiratory Tract Infections, Urinary Tract Infections and other bacterial infectionsCTRI/2012/09/002989irma Limited30
尚未招募
1 期
To study the effect of AYUSH AGT lotion in Dandruff.CTRI/2020/03/024092central council for research in ayurvedic sciences ministry of ayush govt of india
已完成
不适用
A study to find the efficacy and safety of BioMinox A DD for the treatment of dandruff and hair lossCTRI/2012/08/002869Sante Mernaud Pharmaceuticals Pvt Ltd15
尚未招募
2 期
An Clinical Study of Evecare Forte Liquid in PCOS (Polycystic Ovarian Syndrome)CTRI/2017/12/011004The Himalaya Drug Company